689 related articles for article (PubMed ID: 14754422)
1. Theoretical possibilities for the development of novel antiarrhythmic drugs.
Varró A; Biliczki P; Iost N; Virág L; Hála O; Kovács P; Mátyus P; Papp JG
Curr Med Chem; 2004 Jan; 11(1):1-11. PubMed ID: 14754422
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of cardiac potassium channels.
Li GR; Dong MQ
Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
[TBL] [Abstract][Full Text] [Related]
4. Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
Knobloch K; Brendel J; Rosenstein B; Bleich M; Busch AE; Wirth KJ
Med Sci Monit; 2004 Jul; 10(7):BR221-8. PubMed ID: 15232496
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels.
Yang IC; Scherz MW; Bahinski A; Bennett PB; Murray KT
J Pharmacol Exp Ther; 2000 Sep; 294(3):955-62. PubMed ID: 10945846
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological modulations of cardiac ultra-rapid and slowly activating delayed rectifier currents: potential antiarrhythmic approaches.
Islam MA
Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):33-46. PubMed ID: 19929823
[TBL] [Abstract][Full Text] [Related]
7. Effects of the chromanol HMR 1556 on potassium currents in atrial myocytes.
Bosch RF; Schneck AC; Csillag S; Eigenberger B; Gerlach U; Brendel J; Lang HJ; Mewis C; Gögelein H; Seipel L; Kühlkamp V
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):281-8. PubMed ID: 12644901
[TBL] [Abstract][Full Text] [Related]
8. Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes.
Yue L; Feng JL; Wang Z; Nattel S
Cardiovasc Res; 2000 Apr; 46(1):151-61. PubMed ID: 10727663
[TBL] [Abstract][Full Text] [Related]
9. Blockers of the slowly delayed rectifier potassium IKs channel: potential antiarrhythmic agents.
Gerlach U
Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):243-52. PubMed ID: 15326915
[TBL] [Abstract][Full Text] [Related]
10. Chromanol 293B inhibits slowly activating delayed rectifier and transient outward currents in canine left ventricular myocytes.
Sun ZQ; Thomas GP; Antzelevitch C
J Cardiovasc Electrophysiol; 2001 Apr; 12(4):472-8. PubMed ID: 11332571
[TBL] [Abstract][Full Text] [Related]
11. Vascular effects of class-III antiarrhythmic drugs: chromanol 293B, but not dofetilide blocks the smooth muscle delayed rectifier K+ channel.
Karle CA; Bauer A; Weretka S; Zitron E; Abushi A; Kreye VA; Schoels W
Basic Res Cardiol; 2002 Jan; 97(1):17-25. PubMed ID: 11998973
[TBL] [Abstract][Full Text] [Related]
12. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization.
Varro A; Baláti B; Iost N; Takács J; Virág L; Lathrop DA; Csaba L; Tálosi L; Papp JG
J Physiol; 2000 Feb; 523 Pt 1(Pt 1):67-81. PubMed ID: 10675203
[TBL] [Abstract][Full Text] [Related]
13. Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.
Wirth KJ; Paehler T; Rosenstein B; Knobloch K; Maier T; Frenzel J; Brendel J; Busch AE; Bleich M
Cardiovasc Res; 2003 Nov; 60(2):298-306. PubMed ID: 14613859
[TBL] [Abstract][Full Text] [Related]
14. Can inhibition of IKur promote atrial fibrillation?
Burashnikov A; Antzelevitch C
Heart Rhythm; 2008 Sep; 5(9):1304-9. PubMed ID: 18774108
[TBL] [Abstract][Full Text] [Related]
15. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
[TBL] [Abstract][Full Text] [Related]
16. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
[TBL] [Abstract][Full Text] [Related]
17. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
Riera AR; Uchida AH; Ferreira C; Ferreira Filho C; Schapachnik E; Dubner S; Zhang L; Moffa PJ
Cardiol J; 2008; 15(3):209-19. PubMed ID: 18651412
[TBL] [Abstract][Full Text] [Related]
18. Effects of chromanol 293B on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.
Du XL; Lau CP; Chiu SW; Tse HF; Gerlach U; Li GR
J Mol Cell Cardiol; 2003 Mar; 35(3):293-300. PubMed ID: 12676544
[TBL] [Abstract][Full Text] [Related]
19. In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling.
Tsujimae K; Murakami S; Kurachi Y
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H793-800. PubMed ID: 18055524
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels.
Thomas D; Kathofer S; Zhang W; Wu K; Wimmer AB; Zitron E; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
Br J Pharmacol; 2003 Nov; 140(5):996-1002. PubMed ID: 14517175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
